Open AccessThe effect of probiotics on gestational diabetes and its complications in pregnant mother and newborn: A systematic review and meta‐analysis during 2010–2020
Author(s) -
Mahdizade Ari Marzie,
Teymouri Samane,
Fazlalian Tayebeh,
Asadollahi Parisa,
Afifirad Roghayeh,
Sabaghan Mohammad,
Valizadeh Fateme,
Ghanavati Roya,
Darbandi Atieh
Publication year - 2022
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.24326
Subject(s) - gestational diabetes , medicine , randomized controlled trial , meta analysis , medline , diabetes mellitus , scopus , pregnancy , gestational age , obstetrics , gestation , endocrinology , genetics , political science , law , biology
This study was aimed to evaluate the effect of probiotics consumption on gestational diabetes (GD) and its complications in pregnant mother and newborn. The study was registered on PROSPERO (CRD42021243409) and all the enrolled articles were collected from four databases (Medline, Scopus, Embase, and Google Scholar) as randomized controlled trials (RCTs) from 2010 to 2020. A total of 4865 study participants from 28 selected studies were included in this review. The present meta‐analysis showed that the consumption of probiotics supplementation has the potential to decrease GD‐predisposing metabolic parameters such as blood glucose level, lipid profile, inflammation, and oxidative markers which may reduce GD occurrence among pregnant women.